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a b s t r a c t
Wepresent a viscometric afﬁnity biosensor for continuousmonitoring of glucose in biological ﬂuids such
as blood and plasma. The sensing principle of this chemico-mechanical sensor is based upon the viscosity
variation of a sensitive ﬂuid with glucose concentration. Basically, this device includes both an actuating
and a sensing piezoelectric diaphragms as well as a ﬂow-resistive microchannel. In order to conﬁne the
sensitiveﬂuidandallowglucosediffusion into the sensor, a free-standingaluminananoporousmembrane
◦
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oncanavalin A
is also used as size-selective interface.Measurements carried out at nominal temperatures of 25 and 37 C
reveal that this sensor topology exhibits a high resolution in the current range of physiological blood
glucose concentrations, i.e. 2–20mM. In addition, complete reversibility was also demonstrated for at
least 3 days. Finally, measurements performed in human blood serum conﬁrm that this sensor fulﬁls all
basic requirements for a use in continuous glucose monitoring of biological ﬂuids.
© 2011 Elsevier B.V. All rights reserved.
extran
. Introduction
A compact, reliable and affordable continuous glucose mon-
toring system is of great interest for medical applications and
ould allow a better diabetes management compared to current
nger pricking (Klonoff, 2005). A strict glycemic control would also
mprove clinical outcomes for critically ill patients in intensive care
nits, impending glycemic excursions (Krinsley, 2004).
Today, existing continuous glucosemonitoring devices are lack-
ng accuracy, stability and robustness, and consequently are not
sed in the intensive care units. Moreover, diabetic patients still
ave to prick their ﬁnger to get precise measurement and calibrate
xisting devices.
Presently, glucosedetectionmethods arebasedonelectrochem-
cal techniques that are hardly compatible with in vivo monitoring.
hese electrochemical measurements are affected by biofouling
the adhesion of biomolecules to surfaces) that degrades the sen-
itivity and reproducibility, thus requiring frequent calibrations
Wang, 2008). Furthermore, unwanted electrochemically active
olecules may interfere with the metabolite of interest, resultingn a lack of reliability (Heller and Feldman, 2008).
An alternative approach to overcome these limitations is afﬁn-
ty sensing. Afﬁnity sensing is more tolerant to biofouling that only
∗ Corresponding author. Tel.: +41 216 937 780; fax: +41 216 933 891.
E-mail address: christophe.boss@epﬂ.ch (C. Boss).
956-5663/$ – see front matter © 2011 Elsevier B.V. All rights reserved.
oi:10.1016/j.bios.2011.09.016increases the time for the system to stabilize, and is also insensi-
tive to electroactive interferences. For these reasons, investigation
on afﬁnity binding sensors has beenundertakenusing various tech-
nologies, such as ﬂuorescence (Ballerstadt et al., 2004, 2006, 2007;
Ballerstadt and Schultz, 2000) or viscosity-based (Beyer et al., 2001;
Diem et al., 2004; Huang et al., 2009; Kuenzi et al., 2011; Zhao et al.,
2007) principle. Recently, hydrogel-based sensors have emerged as
promising tools for afﬁnity sensing (Tierney et al., 2009a, 2009b).
However, the development of biosensors for medical and biologi-
cal applications that allows for long-term reversibility and stability
remains a challenge.
In this context,weproposeanovel chemico-mechanical concept
which aims at detecting viscosity changes of a solution featuring a
selective afﬁnity for glucose. In this paper, we present a viscosity
sensingprinciple basedonan induced liquidﬂow in amicrochannel
upon piezoelectric diaphragm actuation. Both a theoretical model
of the sensorandextensive characterizations in isotonic saline solu-
tion and human blood serum are presented.
2. Sensing principle
2.1. Glucose-dependent viscosity of the sensitive ﬂuidThe sensitive ﬂuid used within the sensor is the key element for
glucose detection. This is based on the competitive afﬁnity of two
saccharides, namely glucose and dextran, to a speciﬁc saccharide-
binding protein, Concanavalin A (ConA). The sensing principle was
224 C. Boss et al. / Biosensors and Bioele
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is suddenly applied to the actuating diaphragm for a given time,
and then it is switched off. These states generate a strain in the
piezoelectric membrane that in turn will create some pressure in
the ﬂuid. Due to its small cross section, themicrochannel exhibits aig. 1. (a) Principle of the glucose sensitive ﬂuid: competitive binding of glucose
nd dextran on ConA in the case of low and high glucose concentrations. (b) Char-
cteristics of the low viscosity sensitive ﬂuid used within the sensor.
rst demonstrated by optical measurement of glucose concentra-
ion using ﬂuorescence-labelled dextran (Schultz et al., 1982), and
hen fromthechange in theviscosityof anaqueousblendofdextran
nd ConA (Ballerstadt and Ehwald, 1994). This competitive afﬁnity
rocess was shown to be reversible and highly sensitive.
This viscosity variation of a sensitive ﬂuid using a high-
olecular-weight dextran is eventually the core of our sensor. At
ow glucose concentration, dextran molecules are cross-linked by
inding to ConA, forming a viscous solution (Fig. 1a). Next, when
he glucose concentration increases, dextran molecules are par-
ially replaced by glucose ones at the binding sites of ConA. As a
esult, the network ConA–dextran is weakened and the viscosity of
he sensing solution decreases.
The viscosity variations are especially strong in the human
lycemic range (2–30mM glucose). Indeed, changes in viscosity as
igh as one order of magnitude in the physiological relevant range
ere reported (Kuenzi et al., 2010). The sensitive ﬂuid viscosity
an also be tailored for the sensor of interest by changing its com-
osition in terms of dextran and ConA. We chose a low viscosity
ensitive ﬂuid, which was characterized using a standard capil-
ary viscometer (Fig. 1b). It is worth noticing that the sensitivity of
he ﬂuid is particularly high in the hypoglycaemic range (2–4mM),ctronics 30 (2011) 223–228
whereas it decreases in the hyperglycaemic range (7–30mM). High
accuracy in hypoglycaemic region is mandatory to make this sen-
sitive ﬂuid particularly well suited for patient monitoring. Beside
that, the sensitive ﬂuid viscosity is highly temperature dependent.
When raising the temperature from 25 to 37 ◦C, the sensitive ﬂuid
viscosity decreases on average by 38%. This dependance should
therefore to be taken into account through calibration whenwork-
ing in physiological conditions.
2.2. Principle of piezoelectric-based viscosity measurements
Basically, viscosity is extracted from the relationship between
pressure and ﬂow when the sensitive solution goes through a
channel. In our experiment, the sensor comprises two microcham-
bers ﬁlled with the sensitive ﬂuid that communicate through a
microchannel and a rigid nanoporous semi-permeable membrane
(Fig. 2a). This membrane has two roles: it conﬁnes the sensitive
ﬂuid inside the sensor (large molecules cannot go through) and
ensures that the glucose can pass through, meaning that the con-
centration in the sensor and in the liquid should be the same. Each
chamber is composed of a ﬂexible piezoelectric diaphragm which
whether deﬂects under voltage (actuating diaphragm) or generates
a voltage under some pressure load (sensing diaphragm).
These actuating and sensing piezoelectric diaphragms together
with the microchannel are the basis for viscosity detection. When
a voltage is applied on the actuating piezoelectric diaphragm, the
latter deﬂects and tends to generate a ﬂow through themicrochan-
nel. Due to its small section, themicrochannel exhibits a resistance
to the ﬂow which depends on the ﬂuid viscosity. Next, the ﬂow
through the microchannel is recorded using the voltage induced
by the sensing piezoelectric deﬂection.
Both transient andharmonic electric signals can be used to actu-
ate the diaphragm (Fig. 2b). The way viscosity is measured will
depend on these wave forms. In transient mode, a constant voltageFig. 2. Schematic cross view of the glucose sensor (a) and description of the mea-
surement methods for viscosity detection (b).
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esistance to the ﬂowwhich depends upon the viscosity of the sen-
itive ﬂuid. The system is characterized by a relaxation time that
epends upon the viscosity of the sensitive ﬂuid: the more viscous
he sensitive ﬂuid, the larger the relaxation time.
Conversely, under harmonic operation, a sinusoidal voltage is
pplied on the actuating diaphragm. This generates an alternative
ow inside the microchannel, which in turn generates a sinusoidal
eﬂection and induced voltage of the sensing diaphragm. Since the
mplitude and the phase shift between the applied and induced
iezoelectric voltages characterizes the viscosity, we have a simple
ool to assess the ﬂuid characteristics: the more viscous the sensi-
ive ﬂuid, the smaller the deﬂection and the larger the phase shift.
.3. Sensor modelling
Modelling aspects of the device are quite important to optimize
he sensor with respect to the expected variation of the sensitive
uid viscosity. A sketch of the sensor principle used for the deriva-
ion of the generic analytical solution is explained in Fig. 3.
Under quasi static conditions, the laminar viscous ﬂow of a liq-
id through a circular channel with a length much greater than its
iameter, is described by the Hagen–Poiseuille equation
= D
4
128L
P (1)
here Q is the volumetric ﬂow rate, D and L are, respectively, the
hannel diameter and length,  is the liquid viscosity and P rep-
esents the pressure drop across the channel.
On the other hand, the deﬂection of the center of a piezoelec-
ric diaphragm depends on the applied voltage and pressure load.
ssuming small deﬂections, the relationship is linear and given by
= ˛V − ˇP (2)
here x is the deﬂection of the piezoelectric diaphragm center, V
he voltage applied to the piezoelectric diaphragm and P the pres-
ure acting against the diaphragm deﬂection. The coefﬁcients ˛
nd ˇ depend on the diaphragm geometry and material proper-
ies. For static deﬂections of a circular multi-layered piezoelectric
iaphragm, their values are obtained from themodel of Deshpande
nd Saggere (2007). As no external voltage is applied to the sensing
iezoelectric diaphragm, its deﬂection only depends on the pres-
ure load:
2 = ˇ2P2 (3)
Actuating chamber (1)
Sensing chamber (2)
L
D
R1
R2
x1 x2
P1
P2
P1, P2 Pressure in chamber 1, 2x1, x2 Deflection of the 
piezoelectric diaphragm 1, 2
R1, R2 Radius of the 
piezoelectric diaphragm 1, 2
L Length of the microchannel
D Diameter of the microchannel
ig. 3. Schematic representation of the viscosity sensing principle with the used
otations for the theoretical calculations.ctronics 30 (2011) 223–228 225
Next, the total volume displaced by a ﬁxed-edge circular
diaphragm under uniform load is given by
V = 1
3
xR2 (4)
where x and R are, respectively, the deﬂection of the center and the
radius of the diaphragm (note that this equation was derived for a
diaphragmunder uniformpressure load andnot for amulti-layered
piezoelectric diaphragm, but we will nevertheless use it as a good
approximation).
The volumetric ﬂow rate through the channel is equal to the
volume change under the sensing piezoelectric diaphragm:
Q = dV
dt
= R
2
2
3
dx
dt
(5)
Coupling the Hagen–Poiseuille ﬂow through the channel with
the piezoelectric diaphragms deﬂections (Eqs. (1)–(5)), and con-
sidering a sinusoidal voltage V1 = V01 sin (ωt) for actuation, we get
the time dependent differential equation:
128LR22ˇ1
3D4
dx2
dt
+
(
R22ˇ2 + R21ˇ1
R21ˇ2
)
x2 = ˛1V01 sin (ωt) (6)
The solution of the differential equation (Eq. (6)) is composed
of a transient and a stationary part. Here, we are mainly interested
in the stationary solution describing the deﬂection of the sensing
piezoelectric diaphragm which is given by:
x2(t) = A sin (ωt − ϕ) (7)
with
A = R
2
1ˇ2
R22ˇ2 + R21ˇ1
˛1V
0
1√
2ω2 + 1
and
ϕ = arctan(ω)
where
 = 128L
3D4
R22R
2
1ˇ2ˇ1
R22ˇ2 + R21ˇ1

is the relaxation time of the system.
This means that when a sinusoidal voltage is applied to the
actuating piezoelectric diaphragm, the sensing diaphragmwill also
deﬂect harmonically, but its amplitude and phase shift will now
depend on the relaxation time of the system which is found to be
proportional to the liquid viscosity (in addition to the geometric
andpiezoelectric diaphragms characteristics). Next, thesemechan-
ical signals will generate electrical waveforms that will be used to
extract the viscosity of the sensitive ﬂuid.
Aside this analysis, since a time dependent sinusoidal voltage
is applied to the actuating diaphragm, we can wonder if the ﬂow
can still be considered in steady state. When a high viscous liquid
pulsates slowly in a narrow pipe, the instantaneous velocity distri-
bution is given by a parabola as in the case of steady Poiseuille ﬂow.
Uchida (1956) demonstrated that the steady state criteria was still
justiﬁedprovided
√
ω/D  1,whereω is thepulsationof theﬂow,
	 the kinematic viscosity and D the diameter of the channel. As the
sensitive liquid viscosity is several times that of thewater and since
the channel is only somemicrometers diameter, using ω =10 rad/s,
	 =70mm2/s and D=100×10−6 m, we ﬁnd a typical value for the
steady state criteria equal to 4.24×10−2. Therefore, the quasis-
teady condition is satisﬁed and the Hagen–Poiseuille equation can
be used.
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cose level is the same after increasing or decreasing the glucose
concentration.
The reversibility of the sensitive solution was expected since
the reversibility of the ConA-saccharide binding was previously
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. Experimental
.1. Sensitive ﬂuid characteristics
The sensitive ﬂuid was prepared following Kuenzi et al. (2010).
t consists of 2% [w/w] dextran 3200 (PSS) and 0.4% [w/w] ConA
Sigma) in a buffered saline solution (10mM Tris base, 1mMCaCl2,
mM MnCl2, 0.05% NaN3, 0.15M NaCl). Two metal ions, Mn2+ and
a2+, were added to the solution to activate the glucose binding site
f ConA. This conformational change strongly increases its afﬁn-
ty to glucose. The pH was adjusted to the physiological value (pH
.4), which also ensures a maximal proportion of tetrameric ConA
ble to bind up to 4 glucose groups and form a large network. The
aline concentrationwas set to its physiological value (0.15MNaCl)
nd NaN3 was added as preservative. The viscosity of the sensitive
uidwas characterizedusing a capillary viscometer. Its valueswere
anging from 5.9 to 16.7mPa s at 25 ◦C and from 4.2 to 9.4mPa s at
7 ◦C (Fig. 1b).
.2. Sensor architecture
The sensorwas fabricated by stereolithography using a biocom-
atible medical-grade resin (Proform). The actuating diaphragm
as a 3mm diameter, 50m thick disc of lead zirconate titanate
PZT) (Audiowell Electronics) glued onto a 10m thick brass
oil (Goodfellow). On the other hand, the sensing diaphragm
as a 3mm diameter, 28m thick disc of polyvinylidene ﬂuo-
ide (PVDF) (Measurement Specialties) glued onto a 10m thick
rass foil. The semi-permeable membrane was a 50m thick alu-
inananoporousmembranewith2–4nmdiameter pores (Synkera
echnologies). A 100m×100msection glass capillarywas used
or themicrochannel (Vitrocom). The sensor assemblywas realized
sing medical-grade adhesive epoxy (Loctite M-21HP). Finally, the
ensor was 200m thick and contained 4L of sensitive ﬂuid.
.3. In vitro sensor test system
As the viscosity of the sensitive ﬂuid is temperature-dependent,
he whole setup was located in a thermally regulated enclo-
ure (±0.01 ◦C). The sinusoidal voltage generation and acquisition
ere performed using a multifunction DAQ board PCI-6052E from
ational Instrument. The actuating piezoelectric diaphragm was
riven with a low-frequency sinusoidal voltage (1–5Hz) ampliﬁed
p to 30V by means of a high voltage ampliﬁer (WMA-02 from
alco Systems). The sensing voltage was ampliﬁed using an instru-
entation ampliﬁer (AD8661 from Analog Device). The voltage
eneration, acquisition and phase shift computation were per-
ormed using a LabVIEW interface.
To evaluate the characteristics and response of the device, glu-
ose measurements were performed in isotonic saline solution
10mM Tris base, 1mM CaCl2, 1mM MnCl2, 0.05% NaN3, 0.15M
aCl). Glucose solutions of varying concentrations were pumped
nto the test cell using a computer controlled syringe pump (Tecan
avro XCalibur). Subsequently, the devicewas also evaluated using
uman blood serum as a model biological ﬂuid. The human serum
as stored at −20 ◦C. Before use, 0.1% sodium azide (NaN3) was
dded as preservative, then the human serum was ﬁltered (Millex
V0.45msyringeﬁlter) to removeaggregateswhichmayclog the
emi-permeable membrane. Glucose concentration in the human
erum was measured using a standard glucose meter (Accu-Chek).
oncentrated (2M) d-glucose solutions were added to the human
erum to achieve high glucose levels.Since a high voltage is not compatible for in vivo applications,
e can wonder whether a lower actuating voltage could also be
sed. A ﬂow through the whole capillary is required to equilibrate
he glucose concentration inside the capillary. A voltage of 30Vctronics 30 (2011) 223–228
was imposed by the sensor design; it produces a bending of 2.7m
of the diaphragm center, which generates a ﬂow over 1.2mm in
the 100m×100m section glass capillary. The voltage could be
reduced by decreasing themicrochannel dimensions (e.g. a voltage
of 5V could be used with a 500m length, 50m×50m sec-
tion microchannel). Other alternatives could include the reduction
of the piezoelectric layer thickness, as an equivalent electric ﬁeld
would be produced with a lower voltage, or using a microchannel
with a porous side wall, which would allow the glucose diffusion
into the microchannel.
4. Results and discussion
4.1. Sensor characterization at various temperatures
The sensor was characterized at 25 and 37 ◦C. Stepwise increas-
ing levels of glucose concentrations (2–4–7–11–16mM) have
been used, followed by similar decreasing glucose concentrations
(16–11–7–4–2mM) (Fig. 4a). The data indicate that the sensing
principle is highly reversible; the phase shift characterizing a glu-Fig. 4. (a) Phase shift response to stepwise increasing and decreasing glucose con-
centrations (2, 4, 7, 11, 16mM) in isotonic saline solution at 25 and 37 ◦C. (b) Sensor
response to increasing and decreasing glucose concentrations ﬁtted with an expo-
nential model.
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Fig. 5. Phase shift response to 17 full cycles of glucose conc
emonstrated. Nevertheless, the difﬁculty is the conﬁnement of
he sensitive ﬂuid inside the sensor, given that ConA is a small
rotein. The ConA hydrodynamic radius in tetramer conﬁguration
highly prevailing at pH 7.4) is 4.4nmwhereas the nanoporous alu-
ina membrane pores distribution was 2–4nm. The high degree
f reversibility obtained implies that ConA molecules in tetramer
onﬁgurationwerewell conﬁnedby the aluminamembrane.More-
ver, the response time of the sensor did not increase with time,
ndicating that dextran and ConA did not clog the pores. The sens-
ng principle workedwell, glucose diffusing freely in and out of the
ensor through the nanoporous membrane, whereas the sensitive
uid was completely conﬁned inside the sensor.
Finally, we observe that the degree of glucose-induced phase
hift change is reduced by about 55% when the temperature
ncreases. This was expected, since the sensitive ﬂuid viscosity is
ighly temperature dependent. However, the reduced sensitivity
t 37 ◦C does not represent a practical limitation for the detection
f the glucose concentration provided some calibrations are carried
ut.
.2. Sensor response dynamics
The diffusion of glucose in-outside of the sensor was well
escribed by an exponential model, which tends to show that dif-
usion processes are governing the sensor kinetics (Fig. 4b). The
esponse time was determined by ﬁtting the sensor response to
ultiple glucose variations (20 measurements) using an exponen-
ial relationship. At 37 ◦C, the time response of the sensor (time to
each90%of theequilibriumvalue)was3.6±0.7minwhen increas-
ng glucose concentrations, and 12.8±1.4min for the decreasing
ase.
The longer time constant related to decreasing glucose con-
entrations could be explained by a smaller mobility of glucose
olecules in the viscous sensitive ﬂuid with respect to the iso-onic saline solution. This smallermobilitywould increase the time
equired for glucosemolecules to ﬁnd a pore, consequently slowing
own the diffusion process when glucose diffuses out of the sen-
or. Therefore, we expect that the porosity of the semi-permeable
86420
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Fig. 6. In vitro determination of glucose in human blood serum. Measurements[hour]
ions (2mM and 20mM) in isotonic saline solution at 25 ◦C.
membrane affects more the glucose molecules leaving the sensor
than glucose molecules entering the sensor.
The response time achieved by our device was longer than our
targeted 10min response time required for a medical device. This
response time may be shortened by reducing the sensor thickness
since this would decrease the length for molecules to diffuse, and
therefore would decrease the diffusion time. The relaxation time
for diffusion is given by  ∝ L2, where L is the characteristic length.
According to theabove relation, a cavity thicknessof150mshould
achieve a response time less than 10min. Such a dimension is quite
standard in microengineering technologies.
4.3. Glucose sensor reproducibility and stability
For assessing reproducibility and stability, the sensor was
tested in themost relevant physiologically glucose concentrations,
namely 2mM and 20mM (Fig. 5). Seventeen full cycles performed
without interruption during 70h demonstrated a high reversibil-
ity and stability of the sensor. The phase shift difference between
2 and 20mM was constant throughout the measurements. For
each equilibrium value of glucose concentration, 400 measure-
ments were averaged, leading to a mean standard deviation of
0.045◦. The glucose sensitivity was 2.64◦/mM, which combined
with a 95% conﬁdence interval of 0.09◦ (2
), results in an accuracy
of 0.034mM. This value is comparable to the 1mg/dl (0.056mM)
resolution of conventional glucose meters. In addition, when com-
pared to a reference method, most of the glucose meters have
an accuracy characterized by ∼95% of the readings in a ±20%
deviation limit (Brunner et al., 1998). The sensor accuracy corre-
sponds to a relative deviation of ±1.7% for a low hypoglycaemic
value (2mM), which conﬁrms that the sensor resolution is accu-
rate enough for patients monitoring. Moreover, no decrease in
the sensor sensitivity was observed, demonstrating a high stabil-
ity.
Concerning sensor to sensor variability, this is also an important
aspect when moving towards large scale applications, but it can
hardly be addressed in this proof of concept study.
10 12 14 16
e [hour]
carried out in original (5mM) and glucose added (20mM) serum at 25 ◦C.
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.4. In vitro determination of glucose in human serum
Although the speciﬁcity of ConA for glucose was demonstrated
n physiological solutions, once in the blood, some components
ould interfere with the sensitive solutions. Moreover, Mn2+ which
s used to activate ConA, is almost absent in blood, which could
ffect the stability of ConA. Biofouling of the alumina nanoporous
embrane could also be another issue when working in biological
uids. Checking the adequacy of our sensor for in vitro measure-
ents is therefore not trivial.
Therefore, we also tested the sensor in human serum with glu-
ose concentrations of 5mM and 20mM (Fig. 6). Nine changes of
ow and high glucose concentrations were performed during 17h.
good stability of the sensor response was observed, meaning
lso that ConA remains chemically stable in presence of serum,
hich indicates that the lack of Mn2+ does not affect the ConA
ctivation state. Moreover, the response time did not increase
ith time, indicating that biofouling due to protein adsorption on
he semi-permeable membrane, if any, was not an issue and that
lumina nanoporous membranes are well-suited for biosensors
ize-selective interface in biological ﬂuids.
From thesemeasurements, it comesout that the sensor sensitiv-
ty in serum is decreased by about 20% compared to the sensitivity
n isotonic saline solution. After evaluation of the glucose in serum,
he sensor partly recovers its initial sensitivity for isotonic saline
olution. Therefore the loss of sensitivity is reversible, suggesting
hat small biological molecules, most likely glycosylated peptides
r lipids, may diffuse into the sensor and compete with the bind-
ng of glucose to ConA. These experiments conﬁrm that despite
slight loss in sensitivity, the sensitivity of the sensor in serum is
till high enough for glucosemonitoring and the combination of the
onA-based sensitiveﬂuidwith themicroviscometer is apromising
pproach for continuous glucose monitoring in blood.
. ConclusionA viscosity-based afﬁnity sensor for continuous monitoring of
lucose in biological ﬂuids was developed using Concanavalin A
n dextran as sensing ﬂuid. The sensor was extensively tested inctronics 30 (2011) 223–228
isotonic saline solution and in human blood serum for physiologi-
cal blood glucose concentrations between 2 and 20mM. The quite
high accuracy of ±1.7% in the hypoglycaemic range demonstrates
the ability of this sensor for accurate glucose monitoring. A good
degree of reversibility and stability of the sensor was also demon-
strated for up to 3 days. Concerning its time response, we report a
value of 12.8min at 37 ◦C, which in line with the 10min required
for medical applications. These results suggest that the combina-
tion of the ConA-based sensitive ﬂuid and themicroviscometer is a
promising sensing principle for continuous glucose monitoring in
blood. Further work could include testing in human blood serum at
physiological temperature.Usingnewtechnologicaldevelopments,
the sensor to sensor variability could also be addressed.
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